Daiichi Sankyo Company, Limited (OTCMKTS:DSNKY - Get Free Report) hit a new 52-week low on Monday . The stock traded as low as $24.00 and last traded at $24.55, with a volume of 343567 shares changing hands. The stock had previously closed at $25.14.
Daiichi Sankyo Trading Up 6.4 %
The firm has a 50-day simple moving average of $27.36 and a 200-day simple moving average of $32.17.
Daiichi Sankyo (OTCMKTS:DSNKY - Get Free Report) last announced its quarterly earnings data on Friday, January 31st. The company reported $0.22 earnings per share (EPS) for the quarter. As a group, sell-side analysts forecast that Daiichi Sankyo Company, Limited will post 0.82 EPS for the current year.
About Daiichi Sankyo
(
Get Free Report)
Daiichi Sankyo Company, Limited manufactures, markets, and sells pharmaceutical products worldwide. The company offers Enhertu, a HER2 directed antibody drug conjugate; Turalio, a CSF-1R inhibitor; Vanflyta, a FLT3 inhibitor for the treatment of adult patients with relapsed/refractory FLT3-ITD acute myeloid leukemia; ferric carboxymaltose injection for treating anaemia; and Injectafer for the treatment for iron deficiency anaemia.
Recommended Stories
Before you consider Daiichi Sankyo, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Daiichi Sankyo wasn't on the list.
While Daiichi Sankyo currently has a "Hold" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Looking to profit from the electric vehicle mega-trend? Enter your email address and we'll send you our list of which EV stocks show the most long-term potential.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
